At PathoscribeAI, we are pioneering a smarter, faster approach to pharmaceutical R&D through our proprietary AI agent—PathoscribeAI—purpose-built to decode the complexity of biology and medicine.



Founded in 2025 by a collective of AI experts and scientists, our mission is to accelerate therapeutic discovery by transforming how we find, validate, and repurpose medicines.



Whether identifying novel molecules or finding new uses for existing compounds, our platform leverages cutting-edge machine learning, computational biology, and systems pharmacology to turn massive biological datasets into life-saving breakthroughs.



💡 Powered by the PathoscribeAI Agent:

• De novo drug discovery using advanced AI design pipelines

• Drug repurposing through in-silico high-throughput screening

• Intelligent target identification and biomarker prediction

• Clinical and molecular data analysis at scale

• Development pipeline optimization for pharma partners



🌐 Our Vision:

To make AI-driven pharmacology the gold standard—accelerating innovation, improving patient outcomes, and transforming how therapies reach the world.



🚀 We help pharma partners reduce time-to-market, lower R&D costs, and unlock hidden value in their molecular data assets—all through the power of our intelligent agent.



📧 For collaboration: info@pathoscribeai.com



#PathoscribeAI #DrugDiscovery #DrugRepurposing #AIPharma #ComputationalBiology #MachineLearning #HealthcareInnovation #Biotech #PharmaceuticalR&D #TherapeuticDiscovery #InSilicoAnalysis #AIDrugDiscovery #LifeSciencesAI #AIforHealth